Search

for
Search:

GlossaryMonocyte Chemoattractant Protein-1 (MCP-1)

signaling protein that attracts monocytes to inflammation sites

Monocyte Chemoattractant Protein-1 (MCP-1), also known as CCL2, is a signaling protein that plays a crucial role in the immune system by attracting monocytes, a type of white blood cell, to sites of inflammation or injury. This protein is important in the body's response to infection and tissue damage, but excessive MCP-1 activity can contribute to chronic inflammatory diseases.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 500 results

research Anti-Inflammatory and Anti-Hyperplastic Effect of Bazhengsan in a Male Rat Model of Chronic Nonbacterial Prostatitis

7 citations , February 2019 in “Journal of pharmacological sciences”

Bazhengsan reduces inflammation and tissue growth in chronic prostatitis.

research Accelerative Action of Topical Piperonylic Acid on Mice Full Thickness Wound by Modulating Inflammation and Collagen Deposition

3 citations , October 2021 in “PLoS ONE”

Piperonylic acid speeds up wound healing by reducing inflammation and boosting collagen.

research Effects of Ionizing Radiation on Murine Gene Expression in Skin and Bone

January 2017 in “NASA Technical Reports Server (NASA)”

Early changes in skin gene expression can predict later bone mass loss after radiation exposure.

research LL-37 Stimulates the Functions of Adipose-Derived Stromal/Stem Cells via Early Growth Response 1 and the MAPK Pathway

53 citations , April 2016 in “Stem cell research & therapy”

LL-37 helps stem cells grow and move, aiding tissue regeneration and hair growth.

research Radiofrequency Currents Modulate Inflammatory Processes in Keratinocytes

3 citations , October 2024 in “International Journal of Molecular Sciences”

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.

View more "mcp-1" in research →

Community Join

1 / 1 results

community PP405 Identity Research

UmbrellaLabsResearch in Research 292 upvotes 7 months ago

PP405 is a potential hair loss treatment that inhibits mitochondrial pyruvate carriers, increasing lactate dehydrogenase activity and stimulating hair follicle stem cells. In a phase 1 trial, 31% of participants showed over 20% hair density increase with PP405 treatment.